# Belimumab: a step forward in the treatment of systemic lupus erythematosus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/belimumab-a-step-forward-in-the-treatment-of-systemic-lupus-erythematosus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Roberto Depascale,Mariele Gatto,Margherita Zen,Francesca Saccon,Maddalena Larosa,Elisabetta Zanatta,Sara Bindoli,Andrea Doria,Luca Iaccarino |
| Citations | 16 |
| DOI | 10.1080/14712598.2021.1895744 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3132210011 |
| PMID | 33630721 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Roberto Depascale](https://scholariq.org/researchers/roberto-depascale/)

## Paper journal

- [Expert Opinion on Biological Therapy](https://scholariq.org/journals/expert-opinion-on-biological-therapy/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.